How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Isothermal Amplification Kit Market
- By Amplification Technology: Loop-mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), Nucleic Acid Sequence-Based Amplification (NASBA), Helicase-Dependent Amplification (HDA), Strand Displacement Amplification (SDA)
- By Application: Infectious Disease Diagnosis, Genetic Disease Testing, Food Safety Testing, Environmental Testing, Veterinary Diagnostics
- By End User: Clinical Laboratories, Research Laboratories, Point-of-Care Testing Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes
- By Product Type: Reagent Kits, Instruments & Devices, Software & Services
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Loop-mediated Isothermal Amplification (LAMP) leads By Amplification Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.167 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the Isothermal Amplification Kit Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Amplification Technology 5
Application 5
End User 5
Product Type 3
Companies profiled
Abbott Laboratories
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Meridian Bioscience Inc.
New England Biolabs Inc.
Eiken Chemical Co. Ltd.
Lucigen Corporation (LGC Biosearch Technologies)
TwistDx Ltd.
Fujirebio Inc.
Becton
Dickinson and Company (BD)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →QIAGEN N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Bio-Rad Laboratories Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Meridian Bioscience Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →New England Biolabs Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Eiken Chemical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Lucigen Corporation (LGC Biosearch Technologies)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →TwistDx Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Fujirebio Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Becton
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →GenDx
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Alere Inc. (now part of Abbott)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hologic Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Molbio Diagnostics Pvt. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,292M by 2033 · 7.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Loop-mediated Isothermal Amplification (LAMP)53.8
- Recombinase Polymerase Amplification (RPA)10.7
- Nucleic Acid Sequence-Based Amplification (NASBA)10.6
- Helicase-Dependent Amplification (HDA)14.4
- Strand Displacement Amplification (SDA)10.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,515M → $2,637M · 7.2%
Europe$1,056M → $1,932M · 7.8%
Asia Pacific$963.9M → $1,639M · 6.9%
Latin America$596.7M → $1,050M · 7.3%
Middle East and Africa$459.0M → $739.5M · 6.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.632026
7.642027
7.652028
7.662029
7.672030
7.682031
7.702032
7.702033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Abbott Laboratories17.6
- QIAGEN N.V.23.7
- Thermo Fisher Scientific Inc.7.8
- Bio-Rad Laboratories Inc.5.0
- Meridian Bioscience Inc.11.3
- New England Biolabs Inc.6.5
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Amplification Technology22.3%
Application24.7%
End User21.9%
Product Type31.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.0
- Europe24.2
- Asia Pacific20.5
- Latin America13.1
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 92 | 77 | 89 | 99 | 87 | 98 | 90 |
| QIAGEN N.V. | 91 | 73 | 86 | 68 | 70 | 90 | 80 |
| Thermo Fisher Scientific Inc. | 82 | 81 | 67 | 75 | 70 | 68 | 74 |
| Bio-Rad Laboratories Inc. | 59 | 82 | 59 | 63 | 80 | 77 | 70 |
| Meridian Bioscience Inc. | 77 | 58 | 61 | 63 | 65 | 60 | 64 |
| New England Biolabs Inc. | 57 | 48 | 70 | 54 | 55 | 66 | 58 |
| Eiken Chemical Co. Ltd. | 59 | 61 | 44 | 46 | 55 | 57 | 54 |
| Lucigen Corporation (LGC Biosearch Technologies) | 60 | 54 | 38 | 38 | 53 | 49 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Abbott Laboratories
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Abbott Laboratories | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| QIAGEN N.V. | ◐ | − | ✓ | ◐ | ✓ | ✓ |
| Thermo Fisher Scientific Inc. | ✓ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Bio-Rad Laboratories Inc. | − | ✓ | ◐ | − | ◐ | ◐ |
| Meridian Bioscience Inc. | ✓ | − | − | ◐ | − | ◐ |
| New England Biolabs Inc. | ◐ | − | ◐ | − | ◐ | ✓ |
| Eiken Chemical Co. Ltd. | ◐ | ◐ | − | − | ◐ | ◐ |
| Lucigen Corporation (LGC Biosearch Technologies) | ◐ | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Abbott Laboratories90
2QIAGEN N.V.80
3Thermo Fisher Scientific Inc.74
4Bio-Rad Laboratories Inc.70
5Meridian Bioscience Inc.64
6New England Biolabs Inc.58
7Eiken Chemical Co. Ltd.54
8Lucigen Corporation (LGC Biosearch Technologies)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Abbott LaboratoriesQIAGEN N.V.
Challenger2
Strong scale, closing on the leaders.
Thermo Fisher Scientific Inc.Bio-Rad Laboratories Inc.
Contender2
Focused players with pockets of strength.
Meridian Bioscience Inc.New England Biolabs Inc.
Niche2
Specialists in a single segment or region.
Eiken Chemical Co. Ltd.Lucigen Corporation (LGC Biosearch Technologies)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Amplification Technology in North America, then scale across Isothermal Amplification Kit Market — a $318M beachhead inside a $6.21B market.
Beachhead (SOM)$318Mobtainable near-term
Serviceable (SAM)$2.25Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Loop-mediated Isothermal Amplification (LAMP)
Best fit — highest urgency & budget in Amplification Technology.
Economic buyer76 fit
Recombinase Polymerase Amplification (RPA)
Strong fit — clear ROI and a fast path to value.
End user66 fit
Nucleic Acid Sequence-Based Amplification (NASBA)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Amplification Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Amplification Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Isothermal Amplification Kit Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified22%
Evaluation13%
Closed-won5%
$12.4KCAC
$66KLTV
5.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Isothermal Amplification Kit Market is a high-growth opportunity — $1.30B by 2033, compounding at 10.6%.
TAM · 2025$584Mtoday
TAM · 2033$1.30Bforecast
CAGR10.6%2027–2033
Cumulative$8.12Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.30BTotal addressable market
SAM$491MServiceable available market
SOM$87MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.6% CAGR
Demand compounds through 2033, outpacing GDP across Amplification Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Amplification Technology moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.30BLarge & growingTAM by 2033 at 10.6% CAGR
$491MServiceable nowreachable with today’s model
$87MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.02BBear6.9% CAGR
$1.30BBase10.6% CAGR
$1.67BBull13.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Isothermal Amplification Kit Market — a $5.55B market by 2033. Plan: grow share from 11.2% to 17.9%.
Market size · 2033$5.55Btotal addressable
Market CAGR8.1%2027–2033
Target share17.9%from 11.2% today
Revenue ambition$993Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.2% | 17.9% | Ahead |
| Revenue | $595M | $993M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 34.6% | 41.2% | At risk |
| Customer retention | 89.7% | 93.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Amplification Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Amplification Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $103M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Amplification Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Isothermal Amplification Kit Market conversation — a $2.17B market you can size, segment and defend in minutes.
Market size · 2033$2.17Btotal opportunity
Growth4.2%CAGR to 2033
Addressable buyers1,435+accounts in scope
Typical ROI5.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Amplification Technology
Goal Grow share in Amplification Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.6×return on cost, year one
< 3 mopayback period
$55K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Abbott LaboratoriesQIAGEN N.V.Thermo Fisher Scientific Inc.Bio-Rad Laboratories Inc.Meridian Bioscience Inc.New England Biolabs Inc.Eiken Chemical Co. Ltd.Lucigen Corporation (LGC Biosearch Technologies)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Isothermal Amplification Kit Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Isothermal Amplification Kit Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Isothermal Amplification Enzymes Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportIsotetrandrine Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportIsosorbide Mononitrate Tablet Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportIsosorbide Mononitrate Sustained-release Tablet Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportIsosorbide Mononitrate Injection Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportIsosorbide Mononitrate API Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportIsosorbide Mononitrate and Glucose Injection Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportIsosorbide Dinitrate Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportIsorhynchophylline Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportIsorhamnetin Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportIsoproterenol Hydrochloride Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportIsoproterenol Hydrochloride API Market
Market size, share, segmentation and regional forecast.
$871M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.